Multiple Myeloma Cost of Care Under the Oncology Care Model: The Influence of High-Cost Therapies.
Haley TherouxAlaysia WilliamsMark LiuAlyssa DahlTheresa R F DreyerKeith HorvathLuis IsolaPublished in: JCO oncology practice (2020)
The O/E ratio and target prices of the cohorts demonstrate a lack of adequate adjustment to the OCM target price for episodes in which pomalidomide and lenalidomide were used to treat patients with MM.